Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vida Ventures II, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- Ansbert Gadicke - $20.03M in AKTS purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $20.03M in AKTS purchases and sales in the last 12 months
- Helen Susan Kim - $15.03M in AKTS purchases and sales in the last 12 months
- Todd Foley - $4.19M in AKTS purchases and sales in the last 12 months
- Akos Czibere - $1.65M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Vida Ventures II, LLC?
Vida Ventures II, LLC is an investment firm of Aktis Oncology, Inc. (AKTS). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Vida Ventures II, LLC last file a Form 4?
The only primary Form 4 on record is dated 12 January 2026.
Has Vida Ventures II, LLC been buying or selling stock?
Recorded transactions: 2 open-market purchases ($15.03M) and 0 open-market sales across all tracked filings.
